298 related articles for article (PubMed ID: 8752682)
1. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
Kuwabara S; Nakajima M; Moroo I; Hirayama K
Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
7. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of the Guillain-Barré syndrome in childhood by plasmapheresis].
Hernández González A; Rubio Quiñones F; Quintero Otero S; Cozar Navarro L; Cañibano MA; Capote Huelva FJ; Alvarez C; Pantoja Rosso S
An Esp Pediatr; 1993 Sep; 39(3):240-2. PubMed ID: 8250439
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
[TBL] [Abstract][Full Text] [Related]
10. The role of plasmapheresis in childhood Guillain-Barré syndrome.
Epstein MA; Sladky JT
Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
[TBL] [Abstract][Full Text] [Related]
12. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
Hidasi E; Soltész P
Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
[TBL] [Abstract][Full Text] [Related]
14. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
Tagawa Y; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
[TBL] [Abstract][Full Text] [Related]
15. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
Levchenko NI; Piradov MA; Pirogov VN
Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
[TBL] [Abstract][Full Text] [Related]
16. [Clinical use of IM-PH immuno-columns].
Maresca MC; Da Porto A; Cusumano S; Serena M
Ann Med Interne (Paris); 1988; 139 Suppl 1():69-71. PubMed ID: 2854714
[TBL] [Abstract][Full Text] [Related]
17. [IgM antibody against sulfated glucuronyl paragloboside in a case of Guillain-Barré syndrome].
Yoshino H; Shibata S; Arita M
Rinsho Shinkeigaku; 1996 Aug; 36(8):990-2. PubMed ID: 8958754
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
19. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
Zwahlen H; Quadri F; Mombelli G; Tatti V; Marone C
Schweiz Med Wochenschr; 1988 Dec; 118(49):1854-8. PubMed ID: 3217776
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of anti-glycolipid antibody-associated neuropathy].
Yuki N
Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
